No full text
Article (Scientific journals)
Medicaments et grossesse.
Scheen, André
1999In Revue Médicale de Liège, 54 (5), p. 409-14
Peer reviewed
 

Files


Full Text
No document available.

Send to



Details



Keywords :
Abnormalities, Drug-Induced/physiopathology/prevention & control; Drug Therapy; Family Practice; Female; Gynecology; Humans; Pregnancy; Pregnancy Complications/prevention & control; Teratogens/pharmacology
Abstract :
[en] Since the dramatic observations of fetal abnormalities associated to thalidomide use during pregnancy, the risk of malformations when prescribing drugs in pregnant women is a well-known problem, among the public as well as among medical doctors. However, the complexity of the problem, the lack of robust scientific data and the emotional context characterizing this period make the prescription of medications to a pregnant woman a difficult task for every people involved in health care, the pharmacist, the general practitioner and even the gynaecologist.
Disciplines :
Pharmacy, pharmacology & toxicology
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
Scheen, André  ;  Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Language :
French
Title :
Medicaments et grossesse.
Alternative titles :
[fr] Drugs in pregnancy
Publication date :
1999
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Hopital de Baviere, Liège, Belgium
Volume :
54
Issue :
5
Pages :
409-14
Peer reviewed :
Peer reviewed
Available on ORBi :
since 08 May 2009

Statistics


Number of views
79 (2 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0

Bibliography


Similar publications



Contact ORBi